Wildlife Health Global Market Report 2024

The wildlife health market size has grown rapidly in recent years. It will grow from $2.26 billion in 2023 to $2.51 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth observed in the historical period can be ascribed to factors such as habitat destruction, the presence of wildlife veterinary care facilities, advancements in technology for administering medicines to animals in sanctuaries and zoos, and a rise in government initiatives aimed at preventing zoonotic diseases originating from wild reservoirs.

The wildlife health market size is expected to see rapid growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The anticipated growth in the forecast period can be credited to the increasing demand for diverse animal health products, regional opportunities, a rising need for companion animal health products, strategic initiatives by industry leaders, and a heightened demand for veterinary software. Significant trends expected in the forecast period involve worldwide collaboration in disease surveillance, the application of data analytics and artificial intelligence, a proliferation of wildlife conservation measures, programs, and funding activities.

The growth of the wildlife health market is anticipated to be propelled by the increasing incidence of zoonotic diseases. Zoonotic diseases are illnesses or infections that can be transmitted between animals and humans or vice versa. The rise in these diseases is expected to drive the development of various health-related products for wildlife health. For instance, in December 2022, the European Food Safety Authority reported 127,840 cases of zoonotic diseases in Europe in 2021, compared to 120,946 in 2020. Salmonellosis, the second-most reported zoonotic disease, affected 60,050 people in 2022, a significant increase from 52,702 cases in 2020. Thus, the surge in zoonotic diseases is a key factor contributing to the growth of the wildlife health market.

The growth of the wildlife health market is also anticipated to be fueled by wildlife conservation measures and funding activities. Wildlife conservation involves a range of strategies aimed at preserving biodiversity, requiring substantial funding for habitat restoration, anti-poaching efforts, research initiatives, and community engagement. The wildlife health market plays a crucial role in supporting these efforts by providing essential services, diagnostics, and treatments that contribute to the overall well-being of wildlife populations. For instance, in September 2023, the United States Department of the Interior allocated over $40.6 million in grants to 10 states and the U.S. through the U.S. Fish and Wildlife Service, supporting habitat acquisition and protection. Therefore, wildlife conservation measures and funding activities are driving the growth of the wildlife health market.

Advancements in technology represent a significant trend in the wildlife health market. Major companies in the market are adopting new technologies to maintain their competitive position. For example, in August 2021, Merck Animal Health launched WHISPER ON ARRIVAL technology, a specialized sound collection device with a predictive algorithm that analyzes the risk of Bovine Respiratory Disease (BRD). This technology aids farmers and veterinarians in making informed decisions about BRD treatment.

Strategic partnerships are a notable approach adopted by major companies in the wildlife health market to enhance pathogen control in equine environments. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits. In May 2023, the United States Equestrian Federation partnered with Merck Animal Health and ByoPlanet to integrate ByoPlanet's advanced technology with Merck Animal Health's antimicrobial solutions. This collaboration offers a comprehensive approach to enhancing pathogen control in equine environments, addressing wildlife health challenges proactively and introducing innovative products to positively impact the broader wildlife health market, particularly in the equine sector.

In June 2022, Zoetis Inc., a U.S.-based pharmaceutical company, acquired Basepaws for an undisclosed amount. The acquisition of Basepaws is expected to strengthen Zoetis Inc.'s presence in the precision animal health sector and guide future advancements in pet care. Basepaws, a U.S.-based company, specializes in offering DNA tests for cats and dogs.

Major companies operating in the wildlife health market report are Bayer AG, Novartis AG, Merck & Co Inc., Boehringer Ingelheim International GmbH, CSL Limited, Zoetis Inc., Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Génia USA Inc., Ceva Santé Animale, Orion Corporation, Virbac Group, Royal Canin, Emergent BioSolutions Inc., Ceva Santé Animale Group, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Dechra Pharmaceuticals, Huvepharma, Vétoquinol, Vetoquinol S.A., Indian Immunologicals Limited, Norbrook Laboratories Limited, Heska Corporation, Biogenesis Bago, Animalcare Group PLC, Pneu-Dart Inc., PetAg Inc.

North America was the largest region in the wildlife health market in 2023. The regions covered in the wildlife health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wildlife health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of wildlife health include mammals, birds, fish, reptiles, and amphibians. Mammals denote members of the vertebrate animal family whose offspring are nourished by the mother's milk from specific mammary glands. The products comprise medicine, equipment, and consumables, utilizing various routes of administration such as oral, injectable, and others. The end users encompass zoos, wildlife sanctuaries, wildlife rescue and rehabilitation centers, among others.

The wildlife health market research report is one of a series of new reports that provides wildlife health market statistics, including wildlife health industry global market size, regional shares, competitors with a wildlife health market share, detailed wildlife health market segments, market trends and opportunities, and any further data you may need to thrive in the wildlife health industry. This wildlife health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wildlife health market consists of sales of immobilizing drugs, pharmaceutical drugs, and vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.